2026. EFFICACY OF LOW DOSE ORAL MINOXIDIL (1.25 MG) AS MONOTHERAPY IN MALE ANDROGENETIC ALOPECIA. International Journal of Clinical and Biomedical Research. (Jun. 2026), 131–138.